Sign Up Today and Learn More About Trigemina Stock
Invest in or calculate the value of your shares in Trigemina or other pre-IPO companies through EquityZen's platform.
Trigemina Stock
Trigemina develops non-opiate drug formulations and delivery systems for pain therapy.
About Trigemina Stock
Founded
2006
Headquarters
Moraga, CA, US
Total Funding
23.1M
Industries
Content and Publishing, Messaging and Telecommunications, Advertising
Trigemina Press Mentions
Stay in the know about the latest news on Trigemina
Trigemina to Present at Biotech Showcase 2016
prnewswire • Jan 15, 2016
Trigemina Publishes Data Demonstrating that the Activation of Oxytocin Receptors May Provide Clinical Benefit to Migraine Patients
prnewswire • Dec 19, 2015
Trigemina takes $305K to treat recurring pain | VentureBeat | Deals | by Camille Ricketts
venturebeat • May 20, 2015
Trigemina Management
Leadership team at Trigemina
Chief Medical Officer
Shashidhar Kori
Co-Founder
Martin Angst
Join now and verify your accreditation status to gain access to:
- Trigemina Current Valuation
- Trigemina Stock Price
- Trigemina Management
- Available deals in Trigemina and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Trigemina Cap Table and Funding History by Share Class and Liquidity Preferences
- Trigemina Revenue and Financials
- Trigemina Highlights
- Trigemina Business Model
- Trigemina Risk Factors
- Trigemina Research Report from SACRA Research
Trading Trigemina Stock
How to invest in Trigemina stock?
Accredited investors can buy pre-IPO stock in companies like Trigemina through EquityZen funds. These investments are made available by existing Trigemina shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Trigemina stock?
Shareholders can sell their Trigemina stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."